Menarini Group, Newamsterdam Pharma gain EU approval for Ubeslo and Evlarco
Menarini Group and Newamsterdam Pharma received European Commission approval for Ubeslo (Obicetrapib Monotherapy) and Evlarco (Obicetrapib Plus Ezetimibe Fixed-dose Combination).